ENDEFR
Home › United States › REGENERON PHARMACEUTICALS, INC.

REGENERON PHARMACEUTICALS, INC.

Business Corporation · NEW YORK, United States · LEI 549300RCBFWIRX3HYQ56
LEI activegroup parent

Summary

REGENERON PHARMACEUTICALS, INC. is registered in the United States. Its legal form is Business Corporation. REGENERON PHARMACEUTICALS, INC. is the ultimate parent of a group of 2 subsidiaries in 3 countries, as reported to GLEIF. GLEIF gives this reason: no known person controls the entity, for example because its shareholders are diverse. It has 1 direct subsidiary in GLEIF data. The LEI was first issued on 10 Sep 2013 and the record was last updated on 24 Nov 2025; the next renewal is due by 1 Dec 2026. GLEIF's ISIN mapping lists 5 ISINs for this LEI.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formBusiness Corporation
Register · Register website
Registration number1226128
Registration authorityCorporation and Business Entity Database (Division of Corporations, State Records and UCC, Department of State)
JurisdictionUnited States (US-NY)
Registered addressC/O C T CORPORATION SYSTEM, 28 LIBERTY ST., 10005 NEW YORK, United States
Headquarters address777 OLD SAW MILL RIVER ROAD, 10591 TARRYTOWN, United States
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)11 Jan 1988
LEI549300RCBFWIRX3HYQ56
LEI statusactive
LEI first issued10 Sep 2013
LEI record last updated24 Nov 2025
Next LEI renewal1 Dec 2026
Corroboration of the LEI recordfully corroborated

Group membership

REGENERON PHARMACEUTICALS, INC. this entity
REGENERON IRELAND DESIGNATED ACTIVITY COMPANY Ireland
View the whole group: 2 subsidiaries in 3 countries

Parent not reported to GLEIF

  • Direct parent: no known person controls the entity, for example because its shareholders are diverse.
  • Ultimate parent: no known person controls the entity, for example because its shareholders are diverse.

Direct subsidiaries (1)

ISINs mapped to this LEI (5)

US75886F1075 · US75886F2065 · US75886F3055 · US75886FAE79 · US75886FAF45

5 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.